Intralesional Antimony for Bolivian Cutaneous Leishmaniasis

NCT01300975 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fundacion Nacional de Dermatologia

Collaborators